Jeffrey T. Kuethe

Omarigliptin (MK-3102): A Novel Long-Acting DPP-4 Inhibitor for Once-Weekly Treatment of Type 2 Diabetes

Tesfaye Biftu, Ranabir SinhaRoy, Ping Chen et al. · Journal of Medicinal Chemistry · 2014 · 167 citations · Full text

Medicinal Chemistry, Scientific Rationale, Available Dpp-4 Inhibitors +14

A Series of Novel, Highly Potent, and Orally Bioavailable Next-Generation Tricyclic Peptide PCSK9 Inhibitors

Thomas J. Tucker, Mark W. Embrey, Candice Alleyne et al. · Journal of Medicinal Chemistry · 2021 · 140 citations · Full text

A Practical, One-Pot Synthesis of Sulfonylated Pyridines

Kevin M. Maloney, Jeffrey T. Kuethe, Kathleen Linn · Organic Letters · 2010 · 137 citations

Chemical Engineering, Available Pyridines, Engineering +6

Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor

Douglas G. Johns, Louis‐Charles Campeau, Puja Banka et al. · Circulation · 2023 · 118 citations · Full text

The Reaction of α-Diazo-β-hydroxy Esters with Boron Trifluoride Etherate:  Generation and Rearrangement of Destabilized Vinyl Cations. A Detailed Experimental and Theoretical Study

Roberto Pellicciari, Benedetto Natalini, Bahman M. Sadeghpour et al. · Journal of the American Chemical Society · 1996 · 105 citations

Chemical Engineering, Enantioselective Synthesis, Engineering +15